vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
27.35
-0.02 (-0.07%)
Dec 5, 2025, 4:00 PM EST - Market closed
vTv Therapeutics Employees
vTv Therapeutics had 23 employees as of December 31, 2024. The number of employees increased by 7 or 43.75% compared to the previous year.
Employees
23
Change (1Y)
7
Growth (1Y)
43.75%
Revenue / Employee
$739
Profits / Employee
-$1,020,435
Market Cap
339.38M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VTVT News
- 4 weeks ago - vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - vTv Therapeutics Announces New Appointments to its Scientific Advisory Board - GlobeNewsWire
- 2 months ago - vTv Therapeutics Will Participate in INNODIA Symposium at the EASD 61st Annual Meeting - GlobeNewsWire
- 3 months ago - UPDATE -- vTv Therapeutics to Participate in Upcoming September Investor Conferences - GlobeNewsWire
- 3 months ago - vTv Therapeutics to Participate in Upcoming September Investor Conferences - GlobeNewsWire
- 3 months ago - vTv Therapeutics Announces $80 Million Private Placement with Leading Healthcare Institutional Investors and the T1D Fund - GlobeNewsWire
- 4 months ago - vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - vTv Therapeutics Announces USPTO Allowance of Patent Covering Cadisegliatin - GlobeNewsWire